6197 Stock Overview
Solasto Corporation provides medical outsourcing services to medical institutions in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Solasto Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥498.00 |
| 52 Week High | JP¥710.00 |
| 52 Week Low | JP¥484.00 |
| Beta | 0.55 |
| 1 Month Change | -2.73% |
| 3 Month Change | -4.96% |
| 1 Year Change | -24.66% |
| 3 Year Change | -62.72% |
| 5 Year Change | -45.27% |
| Change since IPO | 36.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6197 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 0.6% | 0.4% | -0.7% |
| 1Y | -24.7% | 3.6% | 27.0% |
Return vs Industry: 6197 underperformed the JP Healthcare industry which returned 3.6% over the past year.
Return vs Market: 6197 underperformed the JP Market which returned 27% over the past year.
Price Volatility
| 6197 volatility | |
|---|---|
| 6197 Average Weekly Movement | 3.2% |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 6197 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6197's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1965 | 31,982 | Toru Noda | www.solasto.co.jp |
Solasto Corporation provides medical outsourcing services to medical institutions in Japan. The company’s medical outsourcing services, including medical office work, temporary staffing, and hospital management support. It offers smart hospital, nursing care, and childcare services, as well as engages in the education business.
Solasto Corporation Fundamentals Summary
| 6197 fundamental statistics | |
|---|---|
| Market cap | JP¥45.92b |
| Earnings (TTM) | JP¥4.90b |
| Revenue (TTM) | JP¥133.69b |
9.4x
P/E Ratio0.3x
P/S RatioIs 6197 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6197 income statement (TTM) | |
|---|---|
| Revenue | JP¥133.69b |
| Cost of Revenue | JP¥111.88b |
| Gross Profit | JP¥21.81b |
| Other Expenses | JP¥16.91b |
| Earnings | JP¥4.90b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 13, 2024
| Earnings per share (EPS) | 53.17 |
| Gross Margin | 16.31% |
| Net Profit Margin | 3.67% |
| Debt/Equity Ratio | 117.5% |
How did 6197 perform over the long term?
See historical performance and comparison